Chronic Respiratory Diseases and Lung Cancer Risk

Lung cancer (LC), the leading cause of death due to malignancy in both males and females, is common in patients with coexisting respiratory comorbidities. Many of these share common etiologies with LC such as smoking, biomass fume or occupational exposure, and ambient air pollution, but also a genetic predisposition and/or common pathophysiologic mechanisms, chief among them chronic inflammation, altered immune surveillance, cell injury and increased turnover, to name a few. This common thread puts patients with respiratory comorbidities at increased risk of developing LC. The present article reviews why patients with 5 of the most prevalent chronic respiratory diseases (COPD, asthma, Interstitial Lung Disease, Obstructive Sleep Apnea and Bronchiectasis) are at increased risk of LC and the potential pathological mechanisms underlying this clinically relevant association.

Authors

Institutions

Publication Details

Journal
Archivos de Bronconeumología
Published
2025-10-25
DOI
https://doi.org/10.1016/j.arbres.2025.10.013
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic Respiratory Diseases and Lung Cancer Risk

Mary Salvatore, Luis Seijó, Juan P. Wisnivesky, Eva Polverino et al.
Archivos de Bronconeumología
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Chronic Respiratory Diseases and Lung Cancer Risk

Mary Salvatore, Luis Seijó, Juan P. Wisnivesky, Eva Polverino, Juan Pablo de-Torres, David O. Wilson
article en

Abstract

Lung cancer (LC), the leading cause of death due to malignancy in both males and females, is common in patients with coexisting respiratory comorbidities. Many of these share common etiologies with LC such as smoking, biomass fume or occupational exposure, and ambient air pollution, but also a genetic predisposition and/or common pathophysiologic mechanisms, chief among them chronic inflammation, altered immune surveillance, cell injury and increased turnover, to name a few. This common thread puts patients with respiratory comorbidities at increased risk of developing LC. The present article reviews why patients with 5 of the most prevalent chronic respiratory diseases (COPD, asthma, Interstitial Lung Disease, Obstructive Sleep Apnea and Bronchiectasis) are at increased risk of LC and the potential pathological mechanisms underlying this clinically relevant association.

Archivos de BronconeumologíaVol. 62(3)
University of Pittsburgh (US), Columbia University Irving Medical Center (US), Vall d'Hebron Institut de Recerca (ES), Navarre Institute of Health Research (ES), Vall d'Hebron Hospital Universitari (ES), Clinica Universidad de Navarra (ES), Columbia University (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 56%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.